XML 56 R44.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2022
Stockholders Equity [Line Items]  
Schedule of defined benefit plan, assumptions

Year ended December 31, 

 

    

2022

    

2021

 

Exercise price

$

0.22 - 0.95

$

0.31 - 0.67

Stock price on date of grant

$

0.22 - 0.95

$

0.27 - 0.67

Volatility

 

100 - 111

%  

 

111 - 114

%

Risk-free interest rate

 

0.29 - 0.97

%  

 

0.16 - 1.53

%

Expected life (years)

 

3.0

 

3.0

Dividend yield

 

 

Schedule of stockholders' equity note, warrants or rights

    

    

    

Weighted- 

    

Weighted-

average 

average 

Remaining 

Number of 

Exercise Price 

Contractual

Aggregate 

Shares

per Share

Term (in years)

Intrinsic Value

Outstanding as of December 31, 2020

 

7,602,814

$

0.54

 

4.4

 

$

Granted

 

354,000

 

1.05

 

 

Outstanding as of December 31, 2021

 

7,956,814

 

0.56

 

4.4

Granted

 

 

 

Outstanding and exercisable as of December 31, 2022

7,956,814

$

0.56

4.4

$

Employee Awards [Member]  
Stockholders Equity [Line Items]  
Summary of Employee Awards activity

Weighted-  

Weighted- 

Average

Average

Remaining

Number of

Exercise Price

Contractual 

Aggregate 

    

 Shares

    

per Share

    

Term (in years)

    

Intrinsic Value

Outstanding as of December 31, 2020

7,266,420

$

1.03

5.5

$

167,000

Granted

1,158,000

0.82

  

  

Exercised

 

(394,670)

 

0.52

 

  

 

  

Forfeited or expired

 

(3,126,205)

 

1.04

 

  

 

  

Outstanding as of December 31, 2021

4,903,545

$

1.11

5.3

$

22,000

Granted

250,000

0.34

  

  

Forfeited or expired

 

(216,720)

 

0.87

 

  

 

  

Outstanding as of December 31, 2022

 

4,936,825

 

$

1.08

 

4.4

$

22,000

Exercisable as of December 31, 2022

 

4,564,445

$

1.15

 

4.4

$

4,000

Warrants with Debt [Member]  
Stockholders Equity [Line Items]  
Schedule of stockholders' equity note, warrants or rights

    

    

    

Weighted- 

    

Weighted-

average 

average 

Remaining 

Number of 

Exercise Price 

Contractual

Aggregate 

Shares

per Share

Term (in years)

Intrinsic Value

Outstanding as of December 31, 2020

 

7,421,011

$

0.46

 

2.0

 

$

478,925

Granted

 

1,868,518

 

0.56

 

  

 

  

Expired

 

(1,204,000)

 

0.65

 

  

 

  

Outstanding as of December 31, 2021

 

8,085,529

 

0.58

 

2.8

$

Granted

 

5,785,721

 

0.70

 

Expired

 

(1,756,000)

 

0.40

 

Outstanding and exercisable as of December 31, 2022

12,115,250

$

0.66

3.5

$